Long-term outcomes and survival after laparoscopy-assisted distal gastrectomy for gastric cancer: Three-year survival analysis of a single-center experience in Korea

Authors

  • Han Mo Yoo MD,

    1. Division of Gastrointestinal Surgery, Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea
    Search for more papers by this author
  • Han Hong Lee MD,

    1. Division of Gastrointestinal Surgery, Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea
    Search for more papers by this author
  • Jung Ho Shim MD,

    1. Division of Gastrointestinal Surgery, Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea
    Search for more papers by this author
  • Hae Myung Jeon MD,

    1. Division of Gastrointestinal Surgery, Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea
    Search for more papers by this author
  • Cho Hyun Park MD,

    1. Division of Gastrointestinal Surgery, Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea
    Search for more papers by this author
  • Jun Gi Kim MD,

    1. Minimal Access and Robotic Surgery Center, Seoul St. Mary's Hospital, Seoul, Korea
    Search for more papers by this author
  • Kyo Young Song MD

    Corresponding author
    1. Division of Gastrointestinal Surgery, Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea
    2. Minimal Access and Robotic Surgery Center, Seoul St. Mary's Hospital, Seoul, Korea
    • Division of Gastrointestinal Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul 137-701, Korea. Fax: +82-2-595-2822.===

    Search for more papers by this author

Abstract

Background and Objectives

Laparoscopy-assisted distal gastrectomy (LADG) has been established as an alternative treatment for early gastric cancer (EGC) because of excellent short-term results. However, only a few reports have considered the long-term outcomes of LADG. In this study, we investigated the 3-year outcome and survival of patients who underwent LADG.

Methods

We assessed 182 patients with gastric adenocarcinoma who underwent LADG. The indication for LADG was confined to EGCs (T1N0 or T1N1 cases). The clinicopathological characteristics and long-term survival data of all patients were analyzed.

Results

The overall morbidity and mortality rates of the patients were 11% and 0%, respectively. An analysis of the final pathological stages of the patients revealed that 160 had stage Ia, 20 had stage Ib, and only 2 had stage II. The median follow-up period was 44 months (range, 2–73 months), and there were two recurrences. Five patients died of other causes, but no patients died of a gastric cancer recurrence. The 3-year overall and disease-specific survival rates were 97.3% and 100%, respectively.

Conclusions

LADG for EGC is acceptable in terms of both short- and long-term outcomes. Thus, LADG can be considered a primary treatment for EGC. J. Surg. Oncol. 2011; 104:511–515. © 2011 Wiley-Liss, Inc.

Ancillary